CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Clinical trial NCT03712956 · UNKNOWN
Trial details
- NCT number
- NCT03712956
- Sponsor
- European Institute of Oncology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-25
- Primary completion
- 2023-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.